EVALUATING PSYCHOSOCIAL SUPPORT AND TREATMENT ADHERENCE AMONG RURAL BREAST CANCER PATIENTS ATTENDING PUNJABI TERTIARY HOSPITALS
DOI:
https://doi.org/10.71000/kypv9v03Keywords:
Breast Neoplasms, Medication Adherence, , Oncology Nursing, Psychosocial Support Systems, Rural Health Services, Social Support, Treatment ComplianceAbstract
Background: Breast cancer treatment adherence is critical for improving survival outcomes, yet rural patients often face significant barriers. Psychosocial support has been shown to influence adherence in chronic diseases, but its role among rural breast cancer patients in Pakistan remains underexplored.
Objective: To evaluate the relationship between psychosocial support and treatment adherence among rural breast cancer patients receiving care at two tertiary hospitals in Punjab, Pakistan, and to identify key psychosocial factors influencing adherence.
Methods: This cross-sectional observational study was conducted over eight months at Nishtar Medical University Hospital, Multan, and Allied Hospital, Faisalabad. A total of 200 female breast cancer patients from rural areas were recruited using consecutive sampling. Psychosocial support was assessed using the Multidimensional Scale of Perceived Social Support (MSPSS), and treatment adherence was measured via the Morisky Medication Adherence Scale (MMAS-8). Sociodemographic data were collected through structured interviews. Pearson correlation and multiple linear regression analyses were conducted using SPSS v26.
Results: The mean total MSPSS score was 5.1 (±1.0), with family support rated highest. High adherence (MMAS-8 score ≥6) was observed in 63% of participants. A significant positive correlation was found between total MSPSS and MMAS-8 scores (r = 0.47, p < 0.001). Family support demonstrated the strongest association with adherence (r = 0.42, p < 0.001), followed by support from significant others and friends. Higher education and closer proximity to hospitals also correlated with better adherence.
Conclusion: Psychosocial support, especially from family, plays a crucial role in promoting treatment adherence among rural breast cancer patients. Integrating psychosocial interventions into rural oncology care could enhance treatment continuity and outcomes.
References
Uslu Y, Kocatepe V, Sezgin DS, Uras C. Adherence to adjuvant tamoxifen and associated factors in breast cancer survivors. Support Care Cancer. 2023;31(5):285.
Gori S, Modena A, Foglietta J, Verzè M, Inno A, Casarin A, et al. Adherence to oral hormonal anticancer agents in breast cancer. Tumori. 2023;109(3):262-8.
Toorang F, Sasanfar B, Esmaillzadeh A, Zendehdel K. Adherence to the DASH Diet and Risk of Breast Cancer. Clin Breast Cancer. 2022;22(3):244-51.
Di Maso M, Dal Maso L, Augustin LSA, Puppo A, Falcini F, Stocco C, et al. Adherence to the Mediterranean Diet and Mortality after Breast Cancer. Nutrients. 2020;12(12).
Aghamohammadi V, Salari-Moghaddam A, Benisi-Kohansal S, Taghavi M, Azadbakht L, Esmaillzadeh A. Adherence to the MIND Diet and Risk of Breast Cancer: A Case-control Study. Clin Breast Cancer. 2021;21(3):e158-e64.
Mitchell KR, Boyle JR, Juricekova L, Brown RF. Adjuvant chemotherapy non-adherence, patient-centered communication, and patient-level factors in elderly breast and colon cancer patients. Cancer Med. 2023;12(10):11915-29.
Tan EH, Wong ALA, Tan CC, Wong P, Tan SH, Ang LEY, et al. Beliefs about medicines and adherence in women with breast cancer on adjuvant endocrine therapy. J Health Psychol. 2022;27(5):1111-24.
Nguyen DL, Oluyemi E, Myers KS, Panigrahi B, Mullen LA, Ambinder EB. Disparities Associated With Patient Adherence of Post-Breast-Conserving Surgery Surveillance Imaging Protocols. J Am Coll Radiol. 2021;18(11):1540-6.
Haji-Hersi MF, Tilley S, Shelton CA, Lamb N, Kamdem LK. Drug- and patient-related factors are the strongest predictors of endocrine therapy adherence in breast cancer patients. J Oncol Pharm Pract. 2022;28(5):1070-6.
Sarker R, Islam MS, Moonajilin MS, Rahman M, Gesesew HA, Ward PR. Effectiveness of educational intervention on breast cancer knowledge and breast self-examination among female university students in Bangladesh: a pre-post quasi-experimental study. BMC Cancer. 2022;22(1):199.
Ali A, Xie Z, Stanko L, De Leo E, Hong YR, Bian J, et al. Endocrine adherence in male versus female breast cancer: a seer-medicare review. Breast Cancer Res Treat. 2022;192(3):491-9.
Tan EH, Wong ALA, Tan CC, Wong P, Tan SH, Ang LEY, et al. Facilitators and barriers to medication adherence with adjuvant endocrine therapy in women with breast cancer: a structural equation modelling approach. Breast Cancer Res Treat. 2021;188(3):779-88.
Alatawi Y, Hansen RA, Chou C, Qian J, Suppiramaniam V, Cao G. The impact of cognitive impairment on survival and medication adherence among older women with breast cancer. Breast Cancer. 2021;28(2):277-88.
Peddie N, Agnew S, Crawford M, Dixon D, MacPherson I, Fleming L. The impact of medication side effects on adherence and persistence to hormone therapy in breast cancer survivors: A qualitative systematic review and thematic synthesis. Breast. 2021;58:147-59.
Fleming L, Agnew S, Peddie N, Crawford M, Dixon D, MacPherson I. The impact of medication side effects on adherence and persistence to hormone therapy in breast cancer survivors: A quantitative systematic review. Breast. 2022;64:63-84.
Eliassen FM, Blåfjelldal V, Helland T, Hjorth CF, Hølland K, Lode L, et al. Importance of endocrine treatment adherence and persistence in breast cancer survivorship: a systematic review. BMC Cancer. 2023;23(1):625.
Nair RG, Lee SJC, Berry E, Argenbright KE, Tiro JA, Skinner CS. Long-term Mammography Adherence among Uninsured Women Enrolled in the Breast Screening and Patient Navigation (BSPAN) Program. Cancer Epidemiol Biomarkers Prev. 2022;31(1):77-84.
Neuner JM, Fergestrom N, Pezzin LE, Laud PW, Ruddy KJ, Winn AN. Medication delivery factors and adjuvant endocrine therapy adherence in breast cancer. Breast Cancer Res Treat. 2023;197(1):223-33.
Loibl S, Marmé F, Martin M, Untch M, Bonnefoi H, Kim SB, et al. Palbociclib for Residual High-Risk Invasive HR-Positive and HER2-Negative Early Breast Cancer-The Penelope-B Trial. J Clin Oncol. 2021;39(14):1518-30.
Montagnese C, Porciello G, Vitale S, Palumbo E, Crispo A, Grimaldi M, et al. Quality of Life in Women Diagnosed with Breast Cancer after a 12-Month Treatment of Lifestyle Modifications. Nutrients. 2020;13(1).
Jiang H, Dong Y, Zong W, Zhang XJ, Xu H, Jin F. The relationship among psychosocial adaptation, medication adherence and quality of life in breast cancer women with adjuvant endocrine therapy. BMC Womens Health. 2022;22(1):135.
Zhao M, Zhao J, Chen J, Li M, Zhang L, Luo X, et al. The relationship between medication adherence and illness perception in breast cancer patients with adjuvant endocrine therapy: beliefs about medicines as mediators. Support Care Cancer. 2022;30(12):10009-17.
Schmidt JA, Woolpert KM, Hjorth CF, Farkas DK, Ejlertsen B, Cronin-Fenton D. Social Characteristics and Adherence to Adjuvant Endocrine Therapy in Premenopausal Women With Breast Cancer. J Clin Oncol. 2024;42(28):3300-7.
Bright EE, Finkelstein LB, Nealis MS, Genung SR, Wrigley J, Gu HCJ, et al. A Systematic Review and Meta-Analysis of Interventions to Promote Adjuvant Endocrine Therapy Adherence Among Breast Cancer Survivors. J Clin Oncol. 2023;41(28):4548-61.
Downloads
Published
Issue
Section
License
Copyright (c) 2025 Attiq Ullah, Zahra Hayat , Shehroz Nafees , Seemal Fatima , Irfan Ishaque , Talia Ashfaq , Waqas Ahmad (Author)
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
